Tesamorelin + Ipamorelin Bundle — 4 Vials (3:1)

What the bundle contains

This four-vial bundle supplies Tesamorelin and Ipamorelin in a 3:1 ratio: three vials of Tesamorelin 5mg and one vial of Ipamorelin 5mg. All four are lyophilised powders in separate sealed vials, identical to the single products, at a reduced combined price. Nothing is pre-mixed.

Why these two are bundled

Like the Ipamorelin + CJC-1295 bundle, this pairing brings together a GHRH-receptor analogue and a ghrelin-receptor agonist. Tesamorelin is the full-length 44-residue GHRH analogue with an N-terminal trans-3-hexenoic acid modification, in contrast to the truncated 29-residue CJC-1295 no DAC, and researchers comparing the two GHRH analogues often run both bundles. The 3:1 ratio reflects the quantities most commonly requested for protocols using the pair. Sequence and molecular-weight details are on the individual product pages.

Specification

Three vials of Tesamorelin 5mg and one vial of Ipamorelin 5mg, all verified at ≥99% purity by HPLC. Batch records appear on the component product pages, and Certificates of Analysis are available on request.

Handling and storage

Store all vials at −20°C, protected from light. Reconstitute each vial separately with bacteriostatic water. Tesamorelin, as a 44-residue peptide, benefits from slow diluent addition and gentle swirling. Keep reconstituted solutions at 2–8°C and use within 30 days.

Supplied for laboratory research use only.